Evidence map›Paper›PMID 39077839›Full record

ArticleInternational health2025

Accelerating onchocerciasis elimination in humanitarian settings: lessons from South Sudan.

J N Siewe Fodjo, S R Jada, J Rovarini, Y Y Bol, J Y Carter, A Hadermann, T Lakwo, R Colebunders

Abstract read
In one paragraph

Article in International health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

J N Siewe FodjoGlobal Health Institute, University of Antwerp, Gouverneur Kinsbergen Center, Doornstraat 331, 2610 Wilrijk, Belgium.ORCID 0000-0003-3544-1239
S R JadaAmref Health Africa, UN-OCHA Road, Juba, Republic of South Sudan.
J RovariniAmref Health Africa, UN-OCHA Road, Juba, Republic of South Sudan.ORCID 0009-0002-3421-4405
Y Y BolNeglected Tropical Diseases Unit, Ministry of Health, Ministries Road Juba, Republic of South Sudan.ORCID 0009-0008-1117-8943
J Y CarterAmref Health Africa Headquarters, P.O. Box 30125 Nairobi, Kenya.
A HadermannGlobal Health Institute, University of Antwerp, Gouverneur Kinsbergen Center, Doornstraat 331, 2610 Wilrijk, Belgium.ORCID 0000-0003-1207-5811
T LakwoVector Control Division, Ministry of Health, P.O. Box 7272 Kampala, Uganda.ORCID 0000-0003-2445-5811
R ColebundersGlobal Health Institute, University of Antwerp, Gouverneur Kinsbergen Center, Doornstraat 331, 2610 Wilrijk, Belgium.ORCID 0000-0002-1919-1340

Funding

Amref Health Africa 78719FWO 1296723NR2HC
6 · The paper itself

Abstract

There is persistent meso- and hyperendemicity of onchocerciasis (river blindness) in South Sudan, a country that has endured armed conflict for many years. In 2018, Amref Health Africa, in collaboration with local communities, the South Sudan Ministry of Health and other stakeholders, initiated some interventions, among which was Innovative Approaches to Reduce the Burden of Disease Caused by Onchocerciasis (IARDO) project. This project implemented several strategies, including identifying areas where onchocerciasis elimination programs need strengthening, switching from annual to biannual community-directed treatment with ivermectin (CDTI), additional ivermectin administration to postpartum women and school children and a community-based 'slash and clear' vector control strategy. These measures resulted in increased CDTI coverage, fewer bites from blackfly vectors and decreased onchocerciasis-related morbidity. The feasibility of these interventions, low cost, national government support and community ownership suggest their long-term sustainability.

Indexed as

Disease EradicationIvermectinOnchocerciasisAnimalsAntiparasitic AgentsChildFemaleHumansSouth SudanAntiparasitic AgentsIvermectin

Identifiers

PMID39077839
PMCPMC11879546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.